title: Deal watch: Amgen buys oncolytic virus company.
mesh_terms: D001709:Biotechnology / Q000639:trends*; D017322:Clinical Trials, Phase II as Topic; D004345:Drug Industry / Q000639:trends*; D005818:Genetic Engineering; D018259:Herpesvirus 1, Human / Q000235:genetics; D006801:Humans; D008545:Melanoma / Q000628:therapy; D050504:Oncolytic Viruses; D014481:United States